StonvexLoading…
StonvexStonvexStonvexCore line items from INBX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $1.30M | $1.30M | $1.30M | $0.00 |
Operating Income | $-135.03M | $-104.10M | $-70.29M | $-42.90M |
Net Income | $-140.06M | $-107.22M | $-28.65M | $-43.31M |
EPS (Diluted) | $-9.04 | $-6.93 | $-4.65 | $-2.80 |
Total Assets | $146.48M | $177.47M | $212.12M | $242.64M |
Total Liabilities | $138.49M | $140.64M | $143.56M | $148.20M |
Cash & Equivalents | $124.22M | $153.09M | $186.57M | $216.52M |
Free Cash Flow OCF − CapEx | $-129.82M | $-99.70M | $-65.87M | $-35.92M |
Shares Outstanding | 14.58M | 14.50M | 14.48M | 14.48M |